A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
To predict pathological complete response (pCR) in patients receiving neoadjuvant immunochemotherapy (nICT) for esophageal squamous cell carcinoma (ESCC), we explored the factors that influence pCR after nICT ...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Yu Yang, Yan Yi, Zhongtang Wang, Shanshan Li, Bin Zhang, Zheng Sang, Lili Zhang, Qiang Cao and Baosheng Li Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Hematology | Neoadjuvant Therapy | Skin Cancer | Squamous Cell Carcinoma